Dr. Kimberly Brewer, PhD
Research Scientist, Nova Scotia Health Authority
Staff Scientist, IWK Health Centre
Nova Scotia Health Authority, IWK Health Centre, Biomedical Translational Imaging Centre (BIOTIC)
Molecular imaging, cancer immunotherapy, MRI, drug development
Using Molecular Imaging for the Development of Novel Cancer Therapeutics
There are hundreds of novel cancer therapeutics currently under development in North America. However, only 8% of drugs will make it all the way through clinical trials. Dr. Brewer is interested in using molecular imaging techniques, particularly magnetic resonance imaging (MRI), positron emission tomography (PET), computed tomography (CT) and single photon emission computed tomography (SPECT).
These imaging tools can be used to better understand novel therapeutics at the preclinical stage and to help develop novel biomarkers that will better represent the mechanisms induced by non-chemotherapeutic based cancer therapies, particularly immunotherapies.